Business
Why the Bionomics (ASX:BNO) share price surged 8% higher today
The Bionomics Ltd (ASX: BNO) share price has run higher today after the company announced it has entered an agreement to licence its oncology drug candidate, BNC101, to Carina Biotech. At the market’s close, the Bionomics share price had surged 8.33% to 13 cents.
What’s pushing the Bionomics share price?
The Bionomics share price has marched higher today after the company advised that it will exclusively licence BNC101 to Carina. The agreement will see the development of Chimeric Antigen Receptor T-cell (CAR-T) therapy using Bionomics’ flagship drug. CAR-T is known to harness the body’s immune system to fight against cancer.
According to the company, BNC101 is a high-quality, humanised monoclonal antibody to LGR5, which…
-
General22 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News18 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News11 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General11 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final